The global acute otitis media treatment market is expected to grow at a significant CAGR during the forecast period (2021-2027). Acute otitis media (AOM) is a middle-ear infection that mostly affects kids. The condition causes middle-ear inflammation, resulting in a middle-ear effusion. After upper respiratory tract infection, it is the second most frequent ailment in children. The symptoms of the condition include fever, ear discharge (otorrhoea), irritability, and otalgia and it affects about 80% of children between the ages of 1 and 5. Further, if the disease is left untreated, it can lead to permanent hearing loss. The primary agents of this infection include bacteria and viruses and the main bacteria that causes this infection is Streptococcus pneumonia. Acute otitis media is caused by bacteria in around 35% to 55% of cases, and viruses in nearly 20% to 30% of cases.
To Request a Sample of our Report on Global Acute Otitis Media Treatment Market: https://www.omrglobal.com/request-sample/acute-otitis-media-treatment-market
The global acute otitis media treatment and management market is being driven by the introduction of new products for the treatment of acute otitis media by key players operating in the market. For instance, in August 2020, Sandoz Inc. announced the launch of Ciprofloxacin 0.3% + Dexamethasone 0.1% otic suspension 7.5mL ear drops for the treatment of middle ear and outer ear canal bacterial infections in the US. Ciprofloxacin + Dexamethasone otic suspension is a generic version of Novartis’ Ciprodex (ciprofloxacin and dexamethasone) otic suspension, and it’s given using a regulated dispensing-tip container. Sandoz’s portfolio of high-quality, low-cost antibiotics, has been bolstered by the availability of this crucial drug. Other factors that contribute to an increase in the number of acute otitis media cases include an increase in maternal age and the proportion of mothers who smoke during pregnancy. This, in turn, is accelerating the demand for acute otitis media treatment drugs.
Market Coverage
· The market number available for – 2020-2027
· Base year- 2020
· Forecast period- 2021-2027
· Segment Covered
· Regions Covered- Globally
· Competitive Landscape: Pfizer Inc., Sandoz Inc. (Novartis AG), and GlaxoSmithKline plc, among others.
(Get 15% Discount on Buying this Report)
A full Report of Global Acute Otitis Media Treatment Market is Available at: https://www.omrglobal.com/industry-reports/acute-otitis-media-treatment-market
Global Acute Otitis Media Treatment Market Report by Segment
By Drug Class
• Antibiotics
• Analgesics
• Antipyretic
• NSAIDs
• Antihistamines
• Others
By Distribution Channel
• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies
Global Acute Otitis Media Treatment Market by Region
North America
· United States
· Canada
Europe
· UK
· Germany
· Spain
· France
· Italy
· Rest of Europe
Asia-Pacific
· India
· China
· Japan
· South Korea
· Rest of APAC
Rest of the World
· Latin America
· Middle East & Africa
Reasons to buy from us –
1. We cover more than 15 major industries, further segmented into more than 90 sectors.
2. More than 120 countries are for analysis.
3. Over 100+ paid data sources mined for investigation.
4. Our expert research analysts answer all your questions before and after purchasing your report.
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.
Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +91 7803040404
(This release has been published on Global Market Post. Global Market Post is not responsible for any content included in this release.)
